Gregg H Alton
CIK 1334682 · Chief Patient Officer · last filed 2026-05-26
Gregg H Alton is a Chief Patient Officer who has filed 212 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for CORT, was dated May 26, 2026. Across all open-market trades the lifetime net is −$173.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.55M
7
212
-$173.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Director | — | $82.91 | — | $0 | 8 | 2026-05-26 |
| NVAX | Director | 28,805 | $8.88 | $255.8K | $0 | 9 | 2025-06-24 |
| RENOVARO INC. (RENB) Delisted | Director | — | $1.54 | — | $0 | 2 | 2024-06-27 |
| RENOVARO INC. (ENOB) Delisted | Director | — | $0.70 | — | $0 | 3 | 2023-01-05 |
| GILD | Chief Patient Officer | 58,046 | $125.59 | $7.29M | -$173.46M | 180 | 2019-03-05 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | Director | — | — | — | $0 | 1 | 2015-06-05 |
| Sonoma Pharmaceuticals, Inc. (OCLS) Delisted | Director | — | — | — | $0 | 9 | 2012-10-02 |
Recent Filings
212 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | CORT | Grant (A) | — | $0 | EDGAR |
| 2025-06-24 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | NVAX | Exer (M) | +10,420 | $0 | EDGAR |
| 2025-06-12 | CORT | Grant (A) | — | $0 | EDGAR |
| 2025-02-05 | NVAX | Grant (A) | +7,915 | $67.3K | EDGAR |
| 2024-06-27 | RENOVARO INC. (RENB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | NVAX | Mixed | +6,670 | $0 | EDGAR |
| 2024-05-21 | CORT | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | RENOVARO INC. (RENB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | NVAX | Mixed | +3,100 | $0 | EDGAR |